FDA is Expanding its Case for Quality Program... Should Your Company Participate?

Global Medical Device Podcast · 26 Nov 2019 · 36m · Episode 125

What this episode covers

Mike Drues of Vascular Sciences and John Spear of Greenlight Guru discuss the FDA's expansion of the Case for Quality initiative, a pilot program involving the CMMI Institute and MDIC that shifts focus from mere compliance to true product quality. They analyze the benefits for participating companies, such as exemption from routine inspections and expedited PMA supplement reviews, while debating whether the program's inclusion of non-compliant companies constitutes helpful guidance or inappropriate micromanagement. The conversation highlights the tension between regulatory hurdles and the need for continuous improvement in medical device manufacturing.

Most relevant to

early-stage companies and companies scaling up

Topics

Mentioned

Companies
Greenlight Guru, Vascular Sciences
Also
FDA, MDIC, CMMI Institute, CMMI

Other shows on the same ground, closest first.

  • Let's Combinate · 25m

    155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach

    Laurie Auerbach, President of Compliance Prodigies, LLC, explains FDA Compliance Program 7356.000, clarifying that contract manufacturers (CMOs) and component suppliers selling bundled solutions are legally defined as combination product manufacturers. She highlights common failures in mock Pre-Approval Inspections (PAIs), particularly the misconception that drug GMPs (21 CFR 211) and ICH Q10 fully satisfy device requirements under 21 CFR Part 4. Auerbach emphasizes that sponsors often fail to audit suppliers for device-specific elements like design control, risk management, and specific supplier controls, leading to critical gaps in quality agreements and inspection readiness.

  • Being an Engineer · 51m

    S5E29 Steve Gompertz | Medical Device Quality Control & Regulatory Requirements

    Steve Gompertz, a partner at QRx Partners with prior leadership roles at Medtronic, Boston Scientific, St. Jude Medical, and Pelican Biothermal, explains how to build scalable quality management systems for medical device companies. He details the evolution of regulatory frameworks, noting the shift toward stricter EU standards and the integration of AI and cybersecurity into device compliance. Gompertz emphasizes tailoring quality systems to company size, using a case study of a client who reduced FDA findings from dozens to zero by implementing a holistic, process-connected system rather than a checklist approach. He also advocates for concurrent engineering and cross-functional teams to accelerate development while maintaining rigorous safety standards.

  • Let's Combinate · 9m

    256 - The New FDA Inspection Playbook: Where to Start with QMSR

    Subhi Saadeh, founder of Let’s Combinate, introduces a four-part series on FDA inspection readiness under the new Quality Management System Regulation (QMSR), explaining how the retired QSIT framework has been replaced by Compliance Program 7382.850. He highlights advice from former FDA investigator Eric Pittman, who advises industry to focus exclusively on Section III of compliance programs as the primary roadmap for inspections. The episode details the shift from QSIT’s four major subsystems to six QMS areas, emphasizing a risk-based approach where investigators evaluate product risks and control effectiveness.

  • Let's Combinate · 52m

    128 - Former FDA Inspector and Managing Consultant, Vin Cafiso: Cadavers/Autopsies, Tales from FDA Inspections, Understanding the QMSR, and Quality Culture

    Vin Cafiso, former FDA Consumer Safety Officer and Managing Consultant at Practical Compliance Results, discusses the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR) and its impact on small medical device companies. He explains how FDA inspection methodologies are shifting from issue-focused 483s to process-based QSET audits, emphasizing the importance of understanding quality culture through simple engagement rather than rigid metrics. Cafiso shares insights from his career at companies like BD and Smith & Nephew, highlighting how starting as an investigator builds a strong foundation for industry roles by providing a broad view of quality systems across diverse products and company sizes.

  • Let's Combinate · 30m

    100 - PQMCoach, Our First Recording, Quality (Big Q/little q), Why Predictive Quality Management, and Communicating Quality with Larry Mager

    Larry Mager, Principal at Mgmt-Ctrl and founder of PQMCoach.com, discusses his evolution from a Fortune 500 quality engineer to a startup operator who built a Quality Management System (QMS) from scratch for a cardiovascular device. He explains the shift from 'Big Q' compliance to 'Little Q' operational excellence, detailing how he navigated an FDA consent decree at a large manufacturer and later moved into consulting to address communication barriers in quality management. Mager advocates for Predictive Quality Management (PQM) and the Plan-Do-Check-Act (PDCA) cycle as universal tools for improving business performance across pharma, medical devices, and CROs.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.